Skip to main content

Advertisement

Table 1 Characteristics of the 253 patients with diffuse large B-cell lymphoma (DLBCL)

From: Qualitative visual trichotomous assessment improves the value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in predicting the prognosis of diffuse large B-cell lymphoma

Variable No. of patients [cases (%)]
Sex  
 Men 137 (54.2)
 Women 116 (45.8)
Ann Arbor stage  
 I 48 (19.0)
 II 78 (30.8)
 III 58 (22.9)
 IV 69 (27.3)
IPI score  
 Low (0 or 1) 137 (54.1)
 Low/intermediate (2) 51 (20.2)
 High/intermediate (3) 44 (17.4)
 High (4 or 5) 21(8.3)
Chemotherapy  
 R-EPOCH 25 (9.9)
 R-CHOP 228 (90.1)
  1. IPI, international prognostic index; R, rituximab; CHOP, cyclophosphamide, doxorubicin, vincristine, prednisone; EPOCH, etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin